<DOC>
	<DOC>NCT01078779</DOC>
	<brief_summary>A randomised controlled trial to determine the efficacy of chloroquine for the prevention of influenza</brief_summary>
	<brief_title>The Chloroquine for Influenza Prevention Trial</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Chloroquine</mesh_term>
	<mesh_term>Chloroquine diphosphate</mesh_term>
	<criteria>Age 18 65 Have the ability to provide informed consent If a woman of childbearing potential, willing to use contraception for the period of the trial Acute influenzalike illness at screening History of psoriasis, porphyria cutanea tarda, epilepsy, myasthenia gravis, myopathy of any cause, cardiac arrhythmias, or serious hepatic or renal disease Pregnancy or breast feeding Current use of medication with known serious hepatotoxic effects Current use of medication with known serious interaction with CQ: amiodarone, anticonvulsants, ciclosporin, digoxin, mefloquine, moxifloxacin Current severe depression (as indicated by current use of antidepressant medication) Known serious retinal disease Current or recent (within the past 30 days) participation in any other clinical intervention trial. Known G6PD deficiency Vaccination for influenza (seasonal or H1N1 strain) within the 3 months prior to screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Prevention</keyword>
	<keyword>Chloroquine</keyword>
	<keyword>Randomised controlled trial</keyword>
	<keyword>Respiratory virus infection</keyword>
</DOC>